Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021Business Wire • 12/02/21
Aditxt Announces Pricing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants Led by Leading Healthcare InvestorBusiness Wire • 12/01/21
The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff's Office, to Become First in the Nation to Deploy AditxtScore™ for Immune Scoring for its Employees and First RespondersBusiness Wire • 11/22/21
Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLCBusiness Wire • 11/12/21
Aditxt Partners With CLX Health to Offer AditxtScore™ for COVID-19 Immune Monitoring Service Through CLX's TrustAssure™ PlatformBusiness Wire • 11/03/21
Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021Business Wire • 10/20/21
Aditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021Business Wire • 10/07/21
AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.PRNewsWire • 10/05/21
Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and CanadaBusiness Wire • 10/05/21
Aditxt Appoints Corinne Pankovcin as President and Thomas J. Farley as Chief Financial Officer as Company Prepares for Global CommercializationBusiness Wire • 09/27/21
Aditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster ShotsBusiness Wire • 09/09/21
Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 TherapyBusiness Wire • 09/07/21